ノルエピネフリントランスポーター阻害による交感性血管運動制御の選択的障害
Jens Tank1, Christoph Schroeder, Andre Diedrich
1Clinical Research Center, Helios Klinikum-Berlin, Franz Volhard Clinic, Medical Faculty of the Charité, Humboldt-University, 13125 Berlin, Germany.
Circulation
|June 11, 2003
まとめ
レボキセチンによるノレピネフリントランスポーター (NET) 阻害は,交感性血管運動トーンに対するバロレフレクスの制御を著しく低下させる. この障害は,血管活性薬に対する感受性を高め,薬物相互作用のための新しいメカニズムを強調します.
科学分野:
- 心血管生理学 心血管の生理学
- 自律神経系の規制について
- 薬理学 薬理学とは
背景:
- ノルエピネフリントランスポーター (NET) 阻害は,血管活性薬の反応性と同情反応に影響します.
- この効果は,交感性血管運動トーン調節の障害から生じる可能性があります.
研究 の 目的:
- 選択的なNET阻害が心拍数と交感回路のバロレフレクスの制御に及ぼす影響を調査する.
- 変化した交感性血管運動調節の背後にあるメカニズムを解明する.
主な方法:
- レボキセチン (NET阻害剤) またはプラセボを使用した健康な被験者によるランダム化,ダブルブラインド,クロスオーバー研究.
- 測定には,心拍数,血圧,および筋肉交感神経活動 (MSNA) が含まれていた.
- フェニルエフリンとニトロプルーシドの注入で評価されたバロレフレクスの感受性; 寒冷圧圧テストを使用した.
主要な成果:
- NET阻害は,血圧変化に必要な血管活性剤の投与量を著しく低下させた.
- 心拍のバロレフレクスの制御は類似したが,高血圧にリセットされた.
- MSNAと血圧の振動は,ベースラインとニトロプロシド輸液中に減少しました.
結論:
- NET阻害は,同情性血管運動トーンに対するバロレフレクスの制御を選択的かつ深刻に低下させる.
- この減少は,血管活性薬に対する感受性を高め,新しい薬物相互作用メカニズムを示しています.
さらに関連する動画
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
08:21Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans
Published on: July 21, 2023
関連する概念動画
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:30Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...